Rituximab-augmented myeloablation for first-line autologous stem cell transplantation for mantle cell lymphoma: effects on molecular response and clinical outcome - Dreger, Peter; Rieger, Michael; Seyfarth, Bärbel; Hensel, Manfred; Kneba, Michael; Ho, Anthony Dick; Schmitz, Norbert; Pott, Christiane (Haematologica, the hematology journal, 2007)
Gesehen am 02.11.2021